AptarGroup, Inc. (ATR)
NYSE: ATR · Real-Time Price · USD
169.56
+0.83 (0.49%)
Nov 21, 2024, 11:06 AM EST - Market open
AptarGroup Revenue
AptarGroup had revenue of $909.29M in the quarter ending September 30, 2024, with 1.82% growth. This brings the company's revenue in the last twelve months to $3.57B, up 3.73% year-over-year. In the year 2023, AptarGroup had annual revenue of $3.49B with 4.97% growth.
Revenue (ttm)
$3.57B
Revenue Growth
+3.73%
P/S Ratio
3.12
Revenue / Employee
$258,933
Employees
13,800
Market Cap
11.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.49B | 165.20M | 4.97% |
| Dec 31, 2022 | 3.32B | 95.03M | 2.94% |
| Dec 31, 2021 | 3.23B | 297.88M | 10.17% |
| Dec 31, 2020 | 2.93B | 69.61M | 2.43% |
| Dec 31, 2019 | 2.86B | 94.97M | 3.44% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Solventum | 8.22B |
| Smith & Nephew | 5.64B |
| Catalent | 4.42B |
| Dr. Reddy's Laboratories | 3.58B |
| BioMarin Pharmaceutical | 2.75B |
| Globus Medical | 2.48B |
| Neurocrine Biosciences | 2.24B |
| Sarepta Therapeutics | 1.64B |
ATR News
- 7 days ago - Aptar Named Among Top 50 of the ‘World's Top Companies for Women 2024' by Forbes - Business Wire
- 26 days ago - AptarGroup, Inc. (ATR) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 27 days ago - Aptar Reports Third Quarter 2024 Results - Business Wire
- 4 weeks ago - Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices - Business Wire
- 5 weeks ago - This Elastic Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga
- 5 weeks ago - Aptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly Dividend - Business Wire
- 4 months ago - AptarGroup, Inc. (ATR) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Aptar Reports Second Quarter 2024 Results - Business Wire